Patients with relapsed or refractory lymphomas may benefit from CAR-NK cell immunotherapy and Have fewer adverse events.
Caitlyn Tompkins
Advertisement
Articles by Caitlyn Tompkins
Advertisement
Latest Updated Articles
CAR-NK Cell Immunotherapy Shows PromisePublished: August 15th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
4
FDA Approves First Drug for Pediatrics With Irritable Bowel Syndrome With Constipation
5
